Business Blockbuster - Helpng business to be more visible on Google

Business Daily Media


.

Immuno Cure wins Grand Prize at the National GBA Entrepreneurship Competition

“a prominent recognition attracting RMB 60M investment EOI”

HONG KONG SAR - Media OutReach Newswire - 6 October 2025 - Immuno Cure BioTech ("Immuno Cure") is delighted to announce victory at the National Final of the 1st GBA Entrepreneurship Competition (the "Competition") on 27 September 2025 in Foshan, Guangdong.

Immuno Cure stood out among 7,146 entries nationwide with its first-in-class, therapeutic DNA Vaccine for HIV/AIDS, ICVAX, winning the Grand Prize as the Champion in the Biomedical and Bio-manufacturing Track of the Competition. Further highlighting the event, Immuno Cure attracted an expression of interest for RMB 60 million investment from a major mainland investment fund. Such recognition had demonstrated Immuno Cure's huge potentials in the field of innovative biomedicine.

Dr. Xia JIN, Co-founder and CEO of Immuno Cure, introduced ICVAX in the roadshow (Left) and on stage at the award ceremony of the competition (right).
Dr. Xia JIN, Co-founder and CEO of Immuno Cure, introduced ICVAX in the roadshow (Left) and on stage at the award ceremony of the competition (right).

Jointly hosted by the Ministry of Human Resources and Social Security, the Hong Kong and Macao Work Office, the State Council's Hong Kong and Macao Affairs Office, and the Guangdong Provincial People's Government, the Competition, started in May this year, has brought together high-quality technological and innovative companies nationwide. Over 30% of the contestants in the finals were from Hong Kong and Macao. Dr. Xia JIN, Co-founder and CEO of Immuno Cure fully demonstrating the project's technological breakthrough and market potential throughout several rounds of the Competition.

Immuno Cure's therapeutic DNA Vaccine for HIV/AIDS ("ICVAX") is developed based on the patented technology invented by Professor Zhiwei CHEN and his team at the AIDS Institute of the University of Hong Kong ("HKU"). This technology can significantly enhance cellular immunity and immune response in human, with remarkable effects in controlling viral infections and suppressing tumor growth. Based on the patented technology that was exclusively and globally licensed-in from the HKU, Immuno Cure has developed its "PD-1-Enhanced Vaccine Technology Platform" for the treatment of infectious diseases and a wide range of cancers. Currently, ICVAX has completed the Phase I clinical trial with promising safety and immunogenicity profiles, and will enter Phase II clinical trials shortly. Upon meeting of the endpoints of the Phase II trial, Immuno Cure plans to submit an application for Breakthrough Therapy Designation for ICVAX, aiming for an advanced commercialization in 2028, and bringing a novel solution for global HIV treatment.

Dr. Xia JIN, Co-founder and CEO of Immuno Cure, said: "I am deeply honored in receiving the Grand Prize, which fully demonstrated the judge's high recognition of our cutting-edge technology and the potential of ICVAX. This honor is attributed to the following factors: firstly, it is due to the profound expertise of our team who has been in the field of HIV for decades; secondly, our project targets at HIV, a long-established global challenge, with the goal of developing the world's first solution to HIV; thirdly, our progress has been remarkably rapid and successful, achieving a significant leap from initial cellular-based research to clinical trials in human currently. These strengths are key reasons for our standout success. Furthermore, the EOI of RMB 60 million investment by a major investment fund further reflects the capital market's strong confidence in the market potential of ICVAX. The Greater Bay Area, with its robust innovation ecosystem, abundant investment capital, and vast market, is a fertile ground for biomedical enterprises. Immuno Cure will leverage the advantages of the Greater Bay Area to accelerate the development and commercialization of innovative drugs."

Dr. Percy CHENG, MH, Chairman of Immuno Cure, expressed excitement about the award: "Winning this national award does not only put Immuno Cure in the limelight but also gain a valuable recognition on the merits of our DNA vaccine technology platform. This success is attributed to the dedication of our project team and collaboration partners, without whom we could not have reached this new height. We are committed to focus our expertise and resources on developing more award-winning technologies and products for the sustained long term growth of the Company. "

Immuno Cure continues to uphold its core mission of "translating cutting-edge science into clinical treatment solutions" and contribute to high-quality development of the biomedical industry in the Greater Bay Area.
Hashtag: #ImmunoCure #醫克生物 #医克生物



The issuer is solely responsible for the content of this announcement.

Immuno Cure

Immuno Cure is a clinical stage biotechnology group based in the Hong Kong Science Park, focusing on research and development of innovative DNA medicines and antibody immunotherapies to fight against cancers, inflammatory and infectious diseases based on its patented PD-1-enhanced DNA Vaccine, Anti-Δ42PD1 Antibody; and Vaccine Delivery platforms.

To learn more about Immuno Cure, please visit:

News from Asia

News Lounge Comes to Türkiye, Fostering Dialogue Across Borders

ANTALYA, TURKEY – Media OutReach Newswire – 14 November 2026 – News Lounge, the flagship program of China News Service, welcomed its first group of international guests since its overseas debut in...

TORRAS Launches Two New iPhone Duo Cases from Its Popular Ostand Series, Addressing Foldable Phone Users’ Concerns About Difficult Stand Positioning and Scratches

TOKYO, JAPAN – Media OutReach Newswire – 14 November 2026 – TORRAS (楽創未来株式会社), a mobile accessory brand, has released two stand-equipped iPhone cases compatible with the foldable iPhone Duo...

Sun World Ba Den Mountain marks Vietnam Culture Day, welcoming Cambodian visitors over Bon Om Touk

TAY NINH, VIETNAM – Media OutReach Newswire – 14 November 2026 – Sun World Ba Den Mountain in Tay Ninh province will hold a series of cultural activities marking Vietnam Culture Day on Nov...

Ayam Brand™ Nurtures Healthier Futures with #AyamBersamaMu: Bekal Sihat Masa Depan

The CSR initiative promotes healthier habits among school children through nutrition education, practical food skills, and sustainability, alongside nationwide food donations to orphanages and welf...

Huawei Launches LUTERRA® S2, Redefining the Future of Residential Energy Systems with Three Ultimate Innovations

PALMA, SPAIN – Media OutReach Newswire – 11 November 2026 - Huawei announced the launch of HUAWEI LUTERRA S2, an all-in-one residential energy system that integrates a hybrid inverter, storage, an...

The 27th China International Education Annual Conference held a cloud dialogue, where Yin Yuzhen and Saikaos discussed the exchange of folk ecological education

BEIJING, CHINA – Media OutReach Newswire – 11 November 2026 – The 27th China Annual Conference & Expo for International Education (CACIE) hosted a "CACIE Talk" session in Beijing on October 30...

ATI Secures Manila South Harbour Concession Renewal To 2063

Renewal provides long-term certainty for ATI to advance investment in port modernisation, innovation and sustainable infrastructureMANILA, PHILIPPINES – Media OutReach Newswire – 12 November 2026 ...

Somerset Clarke Quay Singapore To Open On 15 December 2026, As A New Global Flagship For The Somerset Brand

The new flagship property will showcase Somerset's signature approach to harmonious living through active wellness integration, family discovery, and destination-led experiences. SINGAPORE – M...

Ride, eat and save: foodpanda teams up with HelloRide to bring everyday perks to Singaporeans

The partnership connects everyday mobility with food and grocery delivery, giving eligible users more ways to enjoy the convenience of both platformsSINGAPORE – Media OutReach Newswire – 12 Novemb...

SEVENTEEN’s JEONGHAN X JOSHUA Partner With ENYA MUSIC as Global Brand Ambassadors for DREAMSCAPE Collection

The duo JxJ’s co-branded ENYA MUSIC smart instrument series is now available for global pre-order.SHENZHEN, CHINA – Media OutReach Newswire – 12 November 2026 – The core voices behind SEVENTEEN's ...

Why the secrecy around car insurance?

Every year, millions of Australians receive their car insurance renewal and promise themselves they’ll look at it properly later. Then life gets in ...

Australian workers spend almost an hour a day administering email

Research finds email filing, searching and rework consuming an estimated 58 minutes a day and potentially exposing organisations to millionsAustralian...

Customer Service Is Becoming Part of the Small Business Sales and Marketing Engine

For Customer Service Week, 5-9 October, Thryv is urging small businesses to look beyond generating  enquiries and examine what happens after a custome...

Gift Cards as the gateway to agentic payments

Prepaid and stored value gives consumers the trust and control to try AI shopping agents By Blackhawk Network VP Head of ANZ Kieran Nolan For deca...

Why Data Accumulation Without Governance Undermines Sustainability Goals

In July 2026, Group 2 entities, the second cohort of Australian businesses, began their first reporting period under the mandatory climate disclosur...

Permanent $20,000 Instant Asset Write-Off Gives Small Businesses Greater Planning Certainty

The Federal Government’s decision to permanently legislate the $20,000 instant asset write-off will give eligible small businesses greater certainty...